A retrospective study of 308 lung cancer patients who had re-biopsy and 118 patients who had liquid biopsy, found that 134 patients (43.5%) in the re-biopsy group and 49 patients (41.5%) in the liquid biopsy group tested positive for EGFR T790M. This evidence concerns the gene EGFR and lung carcinoma.